Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs Ocumension Therapeutics Mar 13, 2023 18:30 HKT/SGT Read More
Eisai Receives the "Basic Achievement Grand Prize" at the 2023 J-Win Diversity Award Eisai Mar 10, 2023 14:04 HKT/SGT Read More
Eisai Certified as a 2023 Health and Productivity Management Outstanding Eisai Mar 09, 2023 08:07 HKT/SGT Read More
Essex Bio-Technology Announces 2022 Annual Financial Results Essex Bio-Technology Limited Mar 08, 2023 20:28 HKT/SGT Read More
业聚医疗公布上市后首份全年业绩,收入创新高达1.37亿美元,经调整净利润升25%至约26.7百万美元 OrbusNeich Medical Group Holdings Limited Mar 08, 2023 18:02 HKT/SGT Read More
業聚醫療公佈上市後首份全年業績,收入創新高達1.37億美元,經調整淨利潤升25%至約26.7百萬美元 OrbusNeich Medical Group Holdings Limited Mar 08, 2023 18:01 HKT/SGT Read More
OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million OrbusNeich Medical Group Holdings Limited Mar 08, 2023 18:00 HKT/SGT Read More
隨著美國衛生系統面臨越來越大的填補人員空缺的壓力,CGFNS 聯盟發布了外國衛生工作者道德招聘的更新標準 CGFNS International Mar 07, 2023 13:30 HKT/SGT Read More
With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers CGFNS International Mar 07, 2023 13:30 HKT/SGT Read More
随着美国卫生系统面临越来越大的填补人员空缺的压力,CGFNS 联盟发布了外国卫生工作者道德招聘的更新标准 CGFNS International Mar 07, 2023 13:30 HKT/SGT Read More
EC Healthcare Opened the First Organic Flagship Veterinary Hospital in Hong Kong EC Healthcare Mar 06, 2023 15:50 HKT/SGT Read More
エーザイ、「LEQEMBI」についてアルツハイマー病治療薬としてフル承認に向けた生物製剤承認一部変更申請(sBLA)が米国FDAに受理され、優先審査に指定 Eisai Mar 06, 2023 10:00 JST Read More
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease Eisai Mar 06, 2023 09:58 HKT/SGT Read More